Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
SPI Energy Co Ltd ADR

Start price
Target price
Perf. (%)
€9.20
20.11.20
€11.00
20.11.21
-27.72%
10.12.20

Valuable balance sheet
Capable Management
Sustainability is not important
ROE lower than 10% per year
buy
Nel ASA

Start price
Target price
Perf. (%)
€2.12
19.11.20
€2.25
6.79%
27.11.20

Future proof or reliable business model
Innovative
Valuable balance sheet
ROE higher than 10% per year
buy
Vaalco Energy Inc.

Start price
Target price
Perf. (%)
€1.09
19.11.20
-
19.11.21
173.39%
20.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Probably not worthwhile Investment
Nordex SE

Start price
Target price
Perf. (%)
€17.72
18.11.20
-
18.11.21
-14.50%
19.11.21

Revenue growth >5% per year expected
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
ElringKlinger AG

Start price
Target price
Perf. (%)
€12.08
18.11.20
€14.00
12.75%
24.11.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Stable Large shareholder and/or long term investor
buy
Vaalco Energy Inc.

Start price
Target price
Perf. (%)
€1.27
18.11.20
€2.00
18.11.21
6.30%
28.11.20

Could be worthwhile Investment >10% per year
Capable Management
Bad rating
Growths slower than the competition
buy
MagForce AG

Start price
Target price
Perf. (%)
€3.01
18.11.20
€4.00
18.11.21
12.29%
19.11.21

Could be worthwhile Investment >10% per year
buy
Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€60.55
16.11.20
€105.00
16.11.21
-10.40%
28.11.20

Could be worthwhile Investment >10% per year
Good rating
Differentiated customer and product portfolio
Risky balance sheet
buy
Kintara Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.35
16.11.20
€1.00
16.11.21
-45.11%
17.11.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
Adocia

Start price
Target price
Perf. (%)
€7.54
16.11.20
€10.00
16.11.21
18.04%
17.11.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
Genmark Diagnostics

Start price
Target price
Perf. (%)
€11.50
16.11.20
€13.00
16.11.21
-3.48%
30.11.20

Could be worthwhile Investment >10% per year
buy
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€13.20
16.11.20
€15.00
16.11.21
2.27%
30.11.20

Could be worthwhile Investment >10% per year
buy
Cutera Inc.

Start price
Target price
Perf. (%)
€18.10
16.11.20
€20.00
16.11.21
16.02%
30.11.20

Could be very worthwhile Investment >20% year
buy
CHF Solutions Inc

Start price
Target price
Perf. (%)
-
16.11.20
€7.00
16.11.21
-
30.11.20

Could be very worthwhile Investment >20% year
CBAK Energy Technology Inc

Start price
Target price
Perf. (%)
€7.65
16.11.20
€2.00
16.11.21
-75.16%
17.11.21

Probably not worthwhile Investment
SPI Energy Co Ltd ADR

Start price
Target price
Perf. (%)
€6.95
16.11.20
€5.00
16.11.21
32.37%
20.11.20

Valuable balance sheet
Capable Management
Sustainability is not important
ROE lower than 10% per year
Deutsche Pfandbriefbank AG

Start price
Target price
Perf. (%)
€8.00
16.11.20
-
16.11.21
9.13%
24.01.21

Significant cyclical dependencies
Risky Investment
Below average Marketposition
Business model of the past or high risk
buy
HighPoint Resources Corp.

Start price
Target price
Perf. (%)
€5.33
16.11.20
-
16.11.21
110.13%
20.11.20

Could be worthwhile Investment >10% per year
Capable Management
Little innovation
Sierra Metals Inc

Start price
Target price
Perf. (%)
€2.02
16.11.20
-
16.11.21
-7.92%
23.08.21

Could be very worthwhile Investment >20% year
Eldorado Gold Corp.

Start price
Target price
Perf. (%)
€11.41
16.11.20
-
16.11.21
-3.55%
10.12.20

EBIT growth > 30% per year expected
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Mag Silver Corp.

Start price
Target price
Perf. (%)
€15.17
16.11.20
-
16.11.21
-19.78%
30.11.20

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
buy
Innate Pharma

Start price
Target price
Perf. (%)
€4.10
15.11.20
€5.50
15.11.21
7.86%
16.11.21

Could be worthwhile Investment >10% per year
Nordex SE

Start price
Target price
Perf. (%)
€16.70
14.11.20
-
14.11.21
20.60%
04.03.21

Known brand
Innovative
Sustainability is important
Future proof or reliable business model
Aurora Cannabis Inc.

Start price
Target price
Perf. (%)
€5.99
14.11.20
-
14.11.21
35.51%
11.12.20

Probably not worthwhile Investment
Very high cyclical dependencies
Below average Marketposition
Higher risks for its business
buy
Curevac N.V.

Start price
Target price
Perf. (%)
€65.01
14.11.20
-
6.54%
26.11.20

Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation